Navigation Links
Macugen drug for treating degenerative eye disease

The drug Macugen is found to be effective in treating wet age related macular degeneration disease which is a progressive disease// of the macula. Wet age related macular degeneration is caused due to a chronic degenerative disease of the macula region of the eye, macula is present in the retina which is responsible for proper eye sight.

The degenerative disease is caused by the growth of abnormal blood vessel beneath the macula which leads to severe bleeding and accumulation of fluid in retina leading to a condition called Choroidal neovascularization. The new drug Macugen, which is manufactured by Pfizer and OSI Pharmaceuticals, is found to be very effective in treating this degenerative disease by preserving the visual integrity of the macula, the drug is found to stop bleeding and accumulation of fluid in the retina and is found to be very effective than other treatment procedures offered to cure eye disease.


'"/>




Page: 1

Related medicine news :

1. Eye Drug Macugen Shows Allergic Reactions
2. Gene Therapy shows promise in treating Hemophilia
3. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
4. Diuretics are better for treating blood pressure problems than newer medicines
5. A ray of hope in treating blindness and other eye disorders
6. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
7. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
8. Weight reduction by 5% may help in treating nonalcoholic fatty liver disease
9. Lower doses of oral contraceptives helpful in treating acne
10. Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis
11. Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2016)... ... April 30, 2016 , ... ... RANKED Health , a program to critically evaluate and rank health-focused applications ... the program is to provide independent, unbiased and accurate information to help accelerate ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... and CEO of EMED, today signed a multifaceted agreement which will allow for ... Northern Caribbean University Department of Natural and Applied Sciences, Allied Health and Nursing ...
(Date:4/30/2016)... ... , ... well is a challenge for all of us, but there are things we can do to ... “Research is showing more and more that there are simple, yet important steps that can ... age.” Top priorities Dr. Kohli’s recommends for her patients include;, , exercise ...
(Date:4/29/2016)... , ... April 30, 2016 , ... ... of patented products, announces the Pick Up Springboard, an automotive invention that improves ... Truck Manufacturing industry is worth $162 billion," says Scott Cooper, CEO and Creative ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published April 16th ... for Botox and lip injections, which she underwent in order to feel more at ... and Arts Festival. The article explains that Ms. Mirmelli’s situation is not unique; many ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
(Date:4/28/2016)... , April 28, 2016 ... development of innovative peptide and gene-based immunotherapeutics and vaccines for ... will be presenting at the 3rd Annual Growth Capital ... 5 th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology: